Related Experiment Video
Updated: May 12, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Immunomodulatory effects of interferons in malignancies
Joseph Bekisz1, Yuki Sato, Chase Johnson
1Cytokine Biology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD 20892, USA.
Interferon (IFN) exhibits antitumor and immune-stimulating properties, showing promise in treating certain cancers. Combining IFN with monocytes may enhance efficacy against malignancies.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Interferon (IFN) research for antitumor and immunomodulatory effects began in 1957.
- Early studies demonstrated IFN's ability to inhibit viral leukemia in mice and improve survival.
- Purified IFNs confirmed immune cell stimulation leading to direct and indirect antitumor activities.
Purpose of the Study:
- To review the role of interferon (IFN) and monocytes in cancer.
- To explore the therapeutic potential of IFN-alphas (αs) in various malignancies.
- To investigate the combined effects of IFN and monocytes on cancer treatment.
Main Methods:
- Literature review of studies on interferon and monocytes in cancer.
- Analysis of clinical data on IFN-alpha efficacy.
- Examination of the role of monocytes/macrophages in cancer progression.
Main Results:
- IFN-alphas (αs) have shown clinical activity against several tumors, with FDA approval for specific cancers.
- Treatment success with IFNs varies, and some neoplasms do not respond.
- Monocytes/macrophages are crucial in cancer progression, suggesting a potential therapeutic role when combined with IFN.
Conclusions:
- Interferon (IFN) demonstrates antitumor and immunomodulatory capabilities.
- The combination of IFN with monocytes presents a potential therapeutic strategy for various cancers.
- Further investigation into IFN and monocyte interactions is warranted for optimizing cancer treatment.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Tumor Microenvironment
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

